B Lynne Parshall, Director, on September 01, 2026, sold 5,000 shares in Cytokinetics (CYTK) for $357,400. Following the Form 4 filing with the SEC, Parshall has control over a total of 10,784 common shares of the company, with 10,784 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198326000091/xslF345X05/form4.xml
Joseph Michael DePinto, Director, on August 28, 2026, sold 25,000 shares in Brinker International (EAT) for $5,759,750. Following the Form 4 filing with the SEC, DePinto has control over a total of 77,812 common shares of the company, with 77,812 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/703351/000119312526377137/xslF345X05/ownership.xml
Olivier Le Peuch, Director, Chief Executive Officer, on August 31, 2026, sold 5,000 shares in SLB (SLB) for $300,000. Following the Form 4 filing with the SEC, Le Peuch has control over a total of 1,331,328 common shares of the company, with 1,331,328 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/87347/000008734726000120/xslF345X05/form4.xml
John B. Spath, Executive Vice President and Head of Operations, on August 27, 2026, sold 90,000 shares in Talos Energy (TALO) for $1,521,000. Following the Form 4 filing with the SEC, Spath has control over a total of 178,788 common shares of the company, with 178,788 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1724965/000119312526377043/xslF345X05/ownership.xml